Project Grant HT94252510045
Award Date
2/1/25
Completion Date
1/31/28
Dollars Obligated
$593K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
The U.S. Department of the Army Medical Command has awarded a $592,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of California, San Diego (UCSD) to develop a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy". This 3-year research project, running from February 1, 2025 to January 31, 2028, aims to advance innovative biomedical solutions for military personnel and the general public by investigating...
The University of California, San Diego (UCSD) was awarded a $1,218,012 Project Grant from the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE." The research aims to transform health care for Service Members and the American public by investigating medical solutions for the battlefield through innovative and impactful...
The University of California, San Diego (UCSD) was awarded a $789,987.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on August 1, 2023 with a completion date of July 31, 2026, will support research on CTL-tolerant melanoma persister cells. The research aims to transform health care for Service Members and the American public through innovative and impactful research, and to investigate...
The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
The University of California, San Diego (UCSD) was awarded a $551,207.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to research a new therapeutic target to prevent pancreatic cancer metastasis. The 3-year grant period runs from July 1, 2023 to June 30, 2026. The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research in areas like cancer...
The federal Project Grant award, totaling $532,916, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives at the University of California, San Diego (UCSD) focused on "COMBINED EPIGENETIC REPROGRAMMING AND IMMUNOTHERAPY TO TACKLE HIGH-RISK MULTIPLE MYELOMA." The project aims to explore innovative approaches to disease prevention, diagnosis, treatment, and...
The University of California, San Diego was awarded a $553,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to identify NUAK-1 as a novel target for the treatment of appendiceal cancer. The research project commenced on August 15, 2023 and is scheduled for completion on February 14, 2026. The funded activities aim to transform healthcare for Service Members and the American public through...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This $802,068 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of California, San Diego (UCSD) to investigate how sublethal apoptotic signaling promotes melanoma adaptation to immune attack. The research aims to transform health care for service members and the broader public through innovative and impactful biomedical studies. The grant provides funding for UCSD's...
The University of California, San Diego (UCSD) has been awarded a $593,241 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research to identify a new therapeutic target to prevent metastasis in pancreatic cancer. The three-year project, running from July 1, 2023 to June 30, 2026, leverages UCSD's expertise in cognitive science, computer science, and neuroscience to advance artificial intelligence...